Cancer Chemotherapy and Pharmacology

, Volume 1, Issue 2, pp 91–100 | Cite as

New natural products of interest under development at the National Cancer Institute

  • John Douros
  • Matthew Suffness
Original Papers Natural Products
Received:
Accepted:

Summary

Fourteen new agents of natural products origin which are under development as antitumor agents at the National Cancer Institute are discussed with reference to their sources, structures, antitumor activity, current status, and future prospects as clinically effective agents.

Keywords

Cancer Research Natural Product Antitumor Activity National Cancer Institute Future Prospect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bamburg, J. R., Riggs, N. V., Strong, F. M.: Structures of toxins from two strains of Fusarium tricinctum. Tetrahedron 24, 3329–3336 (1968)Google Scholar
  2. Brian, P. W., Dawkins, A. W., Grove, J. F. et al.: Phytotoxic compounds produced by Fusarium equiseti. J. exp. Botany 12, 1–12 (1961)Google Scholar
  3. Cephalotaxus Research Coordinating Group: Cephalotaxine esters in the treatment of acute leukemia: A preliminary clinical assessment. Chinese Medical Journal 2, 263–272 (1976)Google Scholar
  4. Cooney, D. A., Jayaram, H. N., Ryan, T. A., Bono, V. H.: Inhibition of l-asparagine synthetase by a new amino acid antibiotic with anti-tumor activity. l-(αS, 5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazol-acetic acid (NSC-163501). Cancer Chemother. Rep. 58, 793–802 (1974)Google Scholar
  5. Douros, J. D.: Lower plants as a source of anticancer drugs. Cancer Treatm. Rep. 60, 1069–1080 (1976)Google Scholar
  6. Geran, R. L., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M., Abbott, B. J.: Protols for screening chemical agents and natural products against animal tumors and other biological systems (3rd edition). Cancer Chemother. Rep. 3 (2), 1 (1972)Google Scholar
  7. Hanka, L. J., Dietz, A.: U-42,126, a new antimetabolite antibiotic: Production, biological activity and taxonomy of the producing microorganism. Antimicrobial Agents Chemotherapy 3, 425–431 (1973)Google Scholar
  8. Hartwell, J. L.: Types of anticancer agents isolated from plants. Cancer Treatm. Rep. 60, 1031–1067 (1976)Google Scholar
  9. Kupchan, S. M.: Novel plant-derived tumor inhibitors and their mechanisms of action. Cancer Treatm. Rep. 60, 1115–1126 (1976)Google Scholar
  10. Kupchan, S. M., Court, W. A., Dailey, R. G., Jr., et al.: Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J. Amer. chem. Soc. 94, 7194–7195 (1972)Google Scholar
  11. Kupchan, S. M., Komoda, Y., Court, W. A., et al.: Maytansine a novel antileukemic ansa macrolide from Maytenus ovatus. J. Amer. chem. Soc. 94, 1354–1356 (1972)Google Scholar
  12. Kupchan, S. M., Britton, R. W., Ziegler, M. F., et al.: Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica. J. org. Chem. 38, 178–179 (1973)Google Scholar
  13. Kupchan, S. M., Lacadie, J. A., Howie, G. A., Sickles, B. R.: Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoids. J. med. Chem. 19, 1130 (1976)Google Scholar
  14. Kupchan, S. M., Jarvis, B. B., Dailey, R. G., Jr., Bright, W., Bryan, R. F., Shizuri, Y.: Baccharin a novel potent antileukemic trichothecene triepoxide from Baccharis megapotamica. J. Amer. chem. Soc. 98, 7092 (1976)Google Scholar
  15. Neil, G. L., Berger, A. E., Blowers, C. L., Kuentzel, S. L.: l-Glutamine antagonist properties of (αS,5S)α-amino-3-chloro-4,5-dihydro-5-isoxazole-acetic acid (U42,126, NSC-163501) in L1210 cells. Proc. Amer. Ass. Cancer Res. 16, 114 (1975)Google Scholar
  16. Oki, T., Matsuzawa, Y., et al.: New antitumor antibiotics, Aclacinomycins A and B. J. Antibiot. (Tokyo) 28, 830–834 (1975)Google Scholar
  17. Powell, R. G., Weisleder, D., Smith, C. R., et al.: Structures of harringtonine, isoharringtonine, and homoharringtonine. Tetrahedron Lett. 1970, 815–818 (1970)Google Scholar
  18. Wall, M. E., Wani, M. C.: Antineoplastic agents from plants. Ann. Rev. Pharmacol. 17, 117–132 (1977)Google Scholar
  19. Wani, M. C., Taylor, H. L., Wall, M. E., et al.: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Amer. chem. Soc. 93, 2325–2327 (1971)Google Scholar
  20. Wiley, P. F., Johnson, J. L., Houser, D. J.: Nogalomycin analogs having improved antitumor activity. J. Antibiot. (Tokyo) 30, 628–629 (1977)Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • John Douros
    • 1
  • Matthew Suffness
    • 1
  1. 1.Natural Products Branch, Developmental Therapeutics Program, Division of Cancer TreatmentNational Cancer InstituteBethesdaUSA

Personalised recommendations